| Filed On | Filing |
|---|---|
| 21 Sep 2026 | SCHEDULE 13D/A |
| 21 Sep 2026 |
Form 4: Ra Capital MANAGEMENT, L.p., Director and 5 others
Sold 3,448,811 shares ($21.8M) |
| 18 Sep 2026 |
Form 4: Fitzpatrick Jennifer, CLO and Head of Program Mgmt.
Received 56,265 shares as a grant or award · Granted 103,140 Non-Qualified Stock Option (right to buy) · Disposed of 103,140 Non-Qualified Stock Option (right to buy) (Disposition to Issuer) |
| 18 Sep 2026 |
Form 4: McKee Charlotte, CMO and Head of R&D
Received 100,000 shares as a grant or award · Granted 155,700 Non-Qualified Stock Option (right to buy) · Disposed of 155,700 Non-Qualified Stock Option (right to buy) (Disposition to Issuer) |
| 18 Sep 2026 |
Form 4: Ridloff Elena, CFO and CBO
Received 94,537 shares as a grant or award · Granted 165,440 Non-Qualified Stock Option (right to buy) · Disposed of 165,440 Non-Qualified Stock Option (right to buy) (Disposition to Issuer) |
| 18 Sep 2026 |
Form 4: Cloonan Michael, Director
Received 218,050 shares as a grant or award · Granted 436,100 Non-Qualified Stock Option (right to buy) · Disposed of 436,100 Non-Qualified Stock Option (right to buy) (Disposition to Issuer) |
| 17 Sep 2026 | 144 |
| 14 Sep 2026 |
8-K: Costs Associated with Exit or Disposal Activities; Departure/Election of Directors or Officers; Compensation +1 more
Post hoc analyses of SION-719 PreciSION CF subset showed a mean placebo-adjusted sweat chloride |
| 10 Aug 2026 | 8-K: Other Events |
| 06 Aug 2026 | 10-Q |
| 06 Aug 2026 | 8-K: Results of Operations and Financial Condition |
| 09 Jul 2026 |
Form 4: Thompson Peter A., Director
Sold 85,918 shares ($3.85M) |
| 09 Jul 2026 |
Form 4: Orbimed Advisors Llc, Director and 1 other
Sold 85,918 shares ($3.85M) |
| 07 Jul 2026 |
Form 4: Fitzpatrick Jennifer, Chief Legal Officer
Received 10,250 shares by exercise or conversion ($62.6K) · Sold 10,250 shares ($447K) |
| 06 Jul 2026 | 144 |
| 02 Jul 2026 |
Form 4: Thompson Peter A., Director
Sold 115,844 shares ($5.27M) |
| 02 Jul 2026 |
Form 4: Orbimed Advisors Llc, Director and 1 other
Sold 115,844 shares ($5.27M) |
| 18 Jun 2026 |
Form 4: Stelzer Laurie, Director
Granted 17,340 Non-Qualified Stock Option (right to buy) |
| 18 Jun 2026 |
Form 4: Viney Joanne L., Director
Granted 17,340 Non-Qualified Stock Option (right to buy) |
| 18 Jun 2026 |
Form 4: Thompson Peter A., Director
Granted 17,340 Non-Qualified Stock Option (right to buy) |
Loading...